BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 19, 2007
View Archived Issues
Esteve and AstraZeneca patents disclose therapeutic agents for metabolic disorders
Read More
Vertex updates recent developments, outlines 2007 goals
Read More
Ability of N-acetylcysteine to prevent acute renal failure in hypotensives unclear
Read More
Combined erythromycin/metoclopramide therapy shows promise in feed intolerance
Read More
Promising preclinical results for FK-734 in preventing transplant rejection
Read More
Inhibition of endocannabinoid degradation: a novel strategy for the treatment of Parkinson's disease
Read More
WHO awards prequalification status to Rotarix
Read More
Promising antitumor activity of combined therapy with docetaxel and the GHRH antagonist JMR-132
Read More
Viventia reviews late-stage antibody programs
Read More
Anavex Life Sciences reviews neurological pipeline
Read More
Lipomics to support Isis on metabolic drug testing
Read More
Promising results for Hylenex in INFUSE-Morphine study
Read More
MultiCell Technologies advances MCT-475 to preclinical development
Read More
Hemispherx updates avian flu program status
Read More
Kamada submits plans for phase II/III trial of aerosolized AAT
Read More
New phase IIb study evaluates NB-001 for herpes labialis
Read More
Rh-Apo2L begins phase II trials in China
Read More
Neocartilage begins clinical trial
Read More
Ariad advances phase III plans for AP-23573
Read More
Phase I results for SPI-1005 in noise-induced hearing loss reported at the ARO meeting
Read More
Ariad plans IND for AP-24534 for CML
Read More
Copernicus Therapeutics to receive further CFFT funding for CF gene therapy
Read More
Trend toward stabilization of CD4+ count in patients receiving Remune, IR-103
Read More
ELI-216 demonstrates euphoria blocking effect
Read More
Recent Gedeon Richter and Universitaet Wien patents disclose novel analgesic agents
Read More
Conditional approval for Prezista in E.U.
Read More
Priority review for ambrisentan NDA
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More